Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
Target Indication
Manic or Mixed Episode Associated With Bipolar I Disorder
Clinical Trial
NCT00266630Last updated: 12/5/2025
LLY
Eli Lilly and Company